Development of New Strategy for Non-Antibiotic Therapy: Dromedary Camel Lactoferrin Has a Potent Antimicrobial and Immunomodulator Effects


The human and bovine lactoferrin have been studied extensively, but very few reports have been published concerning camel lactoferrin (cLf). The present study aimed to isolate cLf and evaluate its efficiency including antimicrobial activity and immunomodulator effects. cLf isolation was attempted from camel milk whey using a cation exchange chromatography by SP-Sepharose. The antimicrobial activity of the isolated cLf was investigated against Staphylococcus aureus (S. aureus), Streptococcus agalactiae (S. agalactiae), Escherichia coli (E. coli) and Pseudomonas aeruginosa (P. aerogenosa) strains. The immune effect of cLf was studied by lymphocyte transformation test. It was found that cLf was separated around molecular weight of 80 kDa and showed significant inhibitory effect against E. coli followed by P. aeruginosa, S. agalactiae and S. aureus. cLf increased lymphocyte transformations mean values in a dose dependant manner. The highest transformations mean value was determined at 50 μg/mL. In conclusion, these results suggest that cLf is a potent natural antimicrobial and novel immunomodulator agent.


Share and Cite:

A. Ismael, S. Hafez, M. Mahmoud, A. Elaraby and H. Hassan, "Development of New Strategy for Non-Antibiotic Therapy: Dromedary Camel Lactoferrin Has a Potent Antimicrobial and Immunomodulator Effects," Advances in Infectious Diseases, Vol. 3 No. 4, 2013, pp. 231-237. doi: 10.4236/aid.2013.34034.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] K. I. Ereifej, M. H. Alu’datt, H. A. AlKhalidy, I. Alli and T. Rababah, “Comparison and Characterization of Fat and Protein Composition for Camel Milk from Eight Jordanian Locations,” Food Chemistry, Vol. 127, No. 1, 2011, pp. 282-289.
[2] O. A. Al Haj and H. A. Al Kanhal, “Compositional, Technological and Nutritional Aspects of Dromedary Camel Milk,” International Dairy Journal, Vol. 20, No. 12, 2010, pp. 811-821.
[3] I. Phillips, M. Casewell, T. Cox, B. De Groot, C. Friis, R. Jones, C. Nightingale, R. Preston and J. Waddell, “Does the Use of Antibiotics in Food Animals Pose a Risk to Human Health? A Critical Review of Published Data,” Journal of Antimicrobial Chemotherapy, Vol. 53, No. 1, 2004, pp. 28-52.
[4] P. J. Rajala-Schultz, K. L. Smith, J. S. Hogan and B. C. Love, “Antimicrobial Susceptibility of Mastitis Pathogens from First Lactation and Older Cows,” Veterinary Microbiology, Vol. 102, No. 1-2, 2004, pp. 33-42.
[5] A. A. Adesiyun, S. Stoute and B. David, “PreProcessed Bovine Milk Quality in Trinidad: Prevalence and Characteristics of Bacterial Pathogens and Occurrence of Antimicrobial Residues in Milk from Collection Centresm,” Food Control, Vol. 18, No. 4, 2007, pp. 312-320.
[6] P. P. Ward, E. Paz and O. M. Conneely, “Multifunctional Roles of Lactoferrin: A Critical Overview,” Cellular and Molecular Life Sciences, Vol. 62, No. 22, 2005, pp. 2540-2548.
[7] A. S. Naidu, “Lactoferrin: Natural, Multifunctional, Antimicrobial,” CRC Press LLC, Florida, 2000.
[8] E. I. El-Agamy, “Effect of Heat Treatment on Camel Milk Proteins with Respect to Antimicrobal Factors: A Comparison with Cows’ and Buffalo Milk Protein,” Food Chemistry, Vol. 68, No. 2, 2000, pp. 227-232.
[9] D. Levieux, A. Levieux, H. El-Hatmi and J. P. Rigaudière, “Immunochemical Quantification of Heat Denaturation of Camel (Camelus Dromedarius) Whey Proteins,” Journal of Dairy Research, Vol. 72, No. 1, 2006, pp. 1-9.
[10] G. Konuspayeva, B. Faye, G. Loiseau and D. Levieux, “Lactoferrin and Immunoglobulin Contents in Camel’s Milk (Camelus bactrianus, Camelus dromedarius, and Hybrids) from Kazakhstan,” Journal of Dairy Science, Vol. 90, No. 1, 2007, pp. 38-46.
[11] S. Kappeler, Z. Farah and Z. Puhan, “Alternative Splicing of Lactophorin mRNA from Lactating Mammary Gland of the Camel (Camelus dromedarius),” Journal of Dairy Science, Vol. 82, No. 10, 1999, pp. 2084-2093.
[12] El-RM Redwan and Tabll, “Camel Lactoferrin Markedly Inhibits Hepatitis C Virus Genotype 4 Infection of Human Peripheral Blood Leukocytes,” Journal of Immunoassay Immunochemistry, Vol. 28, No. 3, 2007, pp. 267-277.
[13] Y. Liao, X. Du and B. Lönnerdal, “miR-214 Regulates Lactoferrin Expression and Pro-Apoptotic Function in Mammary Epithelial Cells,” Journal of Nutrition, Vol. 140, No. 9, 2010, pp. 1552-1556.
[14] P. H. C. Van Berkel, M. E. J. Geerts, H. A. van Veen, P. M. Kooiman, H. A. Pieper, A. de Boer and J. H. Nuijens, “Glycosylated and Unglycosylated Human Lactoferrins Both Bind Iron and Show Identical Affinities towards Human Lysozyme and Bacterial Lipopoly-Saccharide, but Differ in Their Susceptibilities towards Tryptic Proteolysis,” Biochemical Journal, Vol. 312, No. 1, 1995, pp. 107-114.
[15] E. I. El-Agamy, R. Ruppanner, A. Ismail, C. P. Champagne and R. Assaf, “Purification and Characterization of Lactoferrin, Lactoperoxydase, Lysozyme and Immunoglobulins from Camel’s Milk,” International Dairy Journal, Vol. 6, No. 2, 1996, pp. 129-145.
[16] C. Conesa, L. Sanchez, C. Rota, M. D. Pérez, M. Calvo, S. Farnaud and R. W. Evans, “Isolation of Lactoferrin from Milk of Different Species: Calorimetric and Antimicrobial Studies,” Comparative Biochemistry and Physiology, Part B, Vol. 150, 2008, pp. 131-139.
[17] U. K. Laemmli, “Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4,” Nature, Vol. 227, 1970, pp. 680-685.
[18] H. A. E. Asfour, M. H. Yassin and A. M. Gomaa, “Antibacterial Activity of Bovine Milk Lactoferrin against Some Mastitis Causative Pathogens with Special Regards to Mycoplasmas,” International Journal of Microbiological Research, Vol. 1, No. 3, 2010, pp. 97-105.
[19] N. Richardson, “Standard Methods for the Examination of Dairy Product,” 15th Edition, APHA, Washington DC, 1985.
[20] G. Rai-Elbalhaa, J. L. Pellerin, G. Bodin, H. A. Abdullah and H. Hiron, “Lymphoblastic Transformation Assay of Sheep Peripheral Blood Lymphocytes: A New Rapid and Easy-to-Read Technique,” Comparative Immunology, Microbiology & Infectious Diseases, Vol. 8, No. 3-4, 1985, pp. 311-318.
[21] M. Borenstein, H. Rothstein and J. Cohen, “Sample Power Statistics 10,” SPSS Inc., Chicago, 1997.
[22] H. El-Hatmi, J.-M. Girardet, J.-L. Gaillard, M. H. Yahyaoui and H. Attia, “Characterisation of Whey Proteins of Camel (Camelus dromedarius) Milk and Colostrum,” Small Ruminant Research, Vol. 70, No. 2-3, 2007, pp. 267-271.
[23] E. Fuda, P. Jauregi and D. L. Pyle, “Recovery of Lactoferrin and Lactoperoxidase from Sweet Whey Using Colloidal Gas Aphrons (CGAs) Generated from an Anionic Surfactant,” AOT Biotechnological Progress, Vol. 20, No. 2, 2004, pp. 514-525.
[24] R. Ghosh, “Protein Separation Using Membrane Chromatography: Opportunities and Challenges,” Journal of Chromatograph, Vol. A952, No. 1-2, 2002, p. 13.
[25] D. L. Stewart, D. Purvis and C. R. Lowe, “Affinity Chromatography on Novel Perfluorocarbon Supports: Immobilisation of C.I. Reactive Blue 2 on a Polyvinyl AlcoholCoated Perfluoropolymer Support and Its Application in Affinity Chromatography,” Journal of Chromatograph, Vol. A510, No. 27, 1990, p. 177.
[26] F. J. Wolman, D. Gonzalez Maglio, M. Grasselli and O. Cascone, “One-Step Lactoferrin Purification from Bovine Whey and Colostrum by Affinity Membrane Chromatography,” Journal of Membrane Science, Vol. 288, No. 1-2, 2007, pp. 132-138.
[27] S. Yoshida and X. Y. Ye, “Isolation of Lactoperoxidase and Lactoferrin from Bovine Milk Acid Whey by Carboxymethyl Cation Exchange Chromatography,” Journal of Dairy Science, Vol. 74, No. 5, 1991, pp. 1439-1444.
[28] R. S. Bhimani, Y. Vendrov and P. Furmanski, “Influence of Lactoferrin Feeding and Injection against Systemic Staphylococcal Infections in Mice,” Journal of Applied Microbiology, Vol. 86, No. 1, 1999, pp. 135-144.
[29] S. Farnaud and R. W. Evans, “Lactoferrin: A Multifunctional Protein with Antimicrobial Properties,” Molecular Immunology, Vol. 40, No. 7, 2005, pp. 395-405.
[30] P. Valenti and G. Antonini, “Lactoferrin: An Important Host Defense against Microbial and Viral Attack,” Cellular and Molecular Life Sciences, Vol. 62, No. 22, 2005, pp. 2576-2587.
[31] A. Nacimiento and L. O. Giugliano, “Human Milk Fractions Inhibit the Adherence of Diffusely Adherent Escherichia coli (DAEC) and Enteroaggregative E. coli (EAEC) to HeLa Cells,” FEMS Microbiological Letters, Vol. 184, No. 1, 2000, pp. 91-94.
[32] P. K. Singh, M. R. Parsek, E. P. Greenberg and M. J. Welsh, “A Component of Innate Immunity Prevents Bacterial Biofilm Development,” Nature, Vol. 417, No. 6888, 2002, pp. 552-555.
[33] E. D. Weinberg, “Suppression of Bacterial Biofilm Formation by Iron Limitation,” Medical Hypotheses, Vol. 63, No. 5, 2004, pp. 863-865.
[34] R. Gonzalo, D. Yang, P. Tewary, A. Varadhachary and J. J. Oppenheim, “Lactoferrin Acts as an Alarmin to Promote the Recruitment and Activation of APCs and AntigenSpecific Immune Responses,” Journal of Immunology, Vol. 180, No. 10, 2008, pp. 6868-6876.
[35] M. Zimecki, S. Dariusz, A. S. Pniak and L. K. Marian, “Lactoferrin Regulates Proliferative Response of Human Peripheral Blood Mononuclear Cells to Phytohaemaglutinin and Mixed Lymphocyte Reaction,” Archivum Immunologiae et Therapiae Experimentalis, Vol. 49, No. 2, 2001, pp. 147-154.
[36] E. R. Richie, J. K. Hilliard, R. Gilmore and D. J. Gillespie, “Human Milk Derived Lactoferrin Inhibits Mitogen and Alloantigen Induced Human Lymphocyte Proliferation,” Journal of Reproductive Immunology, Vol. 12, No. 2, 1987, pp. 137-148.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.